ArticleCase reports in oncological medicine2013
Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy.
Article in Case reports in oncological medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.
- Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.The neurologist · 2016Pooled it
- A Case of Acute Encephalopathy After the Initiation of FOLFOX Chemotherapy in a Patient With Colon Cancer.Cureus · 2023Article
- Delayed Posterior Reversible Leukoencephalopathy Syndrome Triggered by FLOT Chemotherapy.Frontiers in neurology · 2019Article
- Secondary mania following cancer chemotherapy with capecitabine.BMJ case reports · 2018Article
- Oxaliplatin-induced posterior reversible encephalopathy syndrome (PRES).BMJ case reports · 2017Article
- Acute hyperammonemic encephalopathy after 5-fluorouracil based chemotherapy.Annals of surgical treatment and research · 2016Article
- PRES with asymptomatic spinal cord involvement. Is this scenario more common than we know?Spinal cord series and cases · 2016Article
- Panitumumab-Associated Encephalopathy after Accidental Intra-arterial Application through Dislocated Central Venous Access Device.Frontiers in neurology · 2016Article
- Posterior reversible encephalopathy syndrome: differences between pregnant and non-pregnant patients.Neurology international · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, visual loss, and characteristic imaging pattern in brain MRI. The cause of PRES is not yet understood. We report a case of a 27-year-old woman that developed PRES after the use of FOLFOX 5 (oxaliplatin/5-Fluoracil/Leucovorin) chemotherapy for a colorectal cancer.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.